United States · FDA National Drug Code directory
Nifedipine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-757_2833cb85-4017-41e2-aa4a-c19371ba85e8
- Product NDC
- 67877-757
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Nifedipine
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220330
- Source listing expiry
- 20261231
Source-listed ingredients
- NIFEDIPINE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-757-01) · 67877-757-01
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-757-05) · 67877-757-05
- 300 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-757-58) · 67877-757-58
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-757-90) · 67877-757-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →